Famin Zhang
Hefei, 230032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Discovery of the 2,3-Dihydrobenzopyrane-4-one as a Potent FTO Inhibitor against Obesity-Related Metabolic Diseases.
Journal: Journal of medicinal chemistry
Published: March 28, 2025
Unraveling the role of host kinase PIM1 in Toxoplasma gondii infection: Implications for therapies.
Journal: PLoS neglected tropical diseases
Published: December 13, 2024
Behavioral alterations in antibiotic-treated mice associated with gut microbiota dysbiosis: insights from 16S rRNA and metabolomics.
Journal: Frontiers in neuroscience
Published: August 09, 2024
TgMIC6 inhibition of autophagy is partially responsible for the phenotypic differences between Chinese 1 Toxoplasma gondii strains.
Journal: International immunopharmacology
Published: March 08, 2024
Toxoplasma gondii Causes Adverse Pregnancy Outcomes by Damaging Uterine Tissue-Resident NK Cells That Secrete Growth-Promoting Factors.
Journal: The Journal of infectious diseases
Published: January 23, 2023
Novel 2-phenyl-4H-chromen derivatives: synthesis and anti-inflammatory activity evaluation in vitro and in vivo.
Journal: Journal of enzyme inhibition and medicinal chemistry
Published: September 21, 2022
Differential expression of TgMIC1 in isolates of Chinese 1 Toxoplasma with different virulence.
Journal: Parasites & vectors
Published: January 24, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026